Temozolomide wafer

N/A

Report date: 2026/04/01 11:26:38
NME

Base Information

Drug NameTemozolomide wafer
Drug Alias NameACX-31 waferCarmustine/temozolomideACX-31
ClassificationSmall molecules
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes CarmustineTemozolomide
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAccurexa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAccurexa Inc
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A